Clinical-stage biotechnology company PharmAust (ASX: PAA) has received approval from the human research ethics committee (HREC) at Sydney’s Macquarie University to start an open-label extension study ...
Source LinkClinical-stage biotechnology company PharmAust (ASX: PAA) has received approval from the human research ethics committee (HREC) at Sydney’s Macquarie University to start an open-label extension study ...
Source Link
Comments